Brokerages Set Astria Therapeutics, Inc. (NASDAQ:ATXS) Price Target at $30.00
Astria Therapeutics, Inc. (NASDAQ:ATXS – Get Free Report) has earned a consensus rating of “Buy” from the eight analysts that are presently covering the stock, Marketbeat reports. Six research analysts have rated the stock with a buy rating and two have issued a strong buy rating on the company. The average twelve-month price objective among […]
Astria Therapeutics, Inc. (NASDAQ:ATXS – Get Free Report) has earned a consensus rating of “Buy” from the eight analysts that are presently covering the stock, Marketbeat reports. Six research analysts have rated the stock with a buy rating and two have issued a strong buy rating on the company. The average twelve-month price objective among […]
